Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.65
Delayed Data
As of Sep 23
 +0.08 / +5.10%
Today’s Change
1.37
Today|||52-Week Range
2.65
-23.96%
Year-to-Date

Today’s Trading

Previous close1.57
Today’s open1.55
Day’s range1.50 - 1.65
Volume93,171
Average volume (3 months)110,341
Market cap$117.3M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+40.54%
Earnings growth (this year)-50.00%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-0.13%
P/E ratioNM
Price/Sales12.13
Price/Book3.56

Competitors

 Today’s
change
Today’s
% change
VVUSVIVUS Inc+0.05+4.63%
MRTXMirati Therapeutics ...-0.58-8.98%
EIGREiger BioPharmaceuti...-0.05-0.36%
SBBPStrongbridge Biophar...+0.69+14.31%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$11.2M
Annual profit (last year)-$13.8M
Net profit margin-122.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President &
Chief Operating Officer
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts

Search for Jobs